<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21867" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Follicle Stimulating Hormone</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Orlowski</surname>
            <given-names>Michelle</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sarao</surname>
            <given-names>Manbeer S.</given-names>
          </name>
          <aff>Griffin Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michelle Orlowski declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Manbeer Sarao declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21867.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Follicle-stimulating hormone (FSH) is a hormone produced by the anterior pituitary in response to gonadotropin-releasing hormone (GnRH) from the hypothalamus.<xref ref-type="bibr" rid="article-21867.r1">[1]</xref>&#x000a0;</p>
        <p>FSH plays a role in sexual development and reproduction in both males and females.</p>
      </sec>
      <sec id="article-21867.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <list list-type="bullet">
          <list-item>
            <p>Fertility</p>
          </list-item>
          <list-item>
            <p>Sexual development</p>
          </list-item>
          <list-item>
            <p>Amenorrhea</p>
          </list-item>
          <list-item>
            <p>Menopause</p>
          </list-item>
          <list-item>
            <p>Pituitary adenomas</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21867.s3" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>FSH is a glycoprotein dimer with alpha and beta subunits. The beta subunit is unique to FSH, while the alpha subunit is the same as in TSH, hCG, and LH.&#x000a0;<xref ref-type="bibr" rid="article-21867.r2">[2]</xref>&#x000a0;</p>
        <p>GnRH stimulates FSH release. The hypothalamus produces GnRH, and it is released into the hypophyseal portal circulation to act on G-protein-coupled receptors at gonadotropic cells of the anterior pituitary. Those gonadotropic cells produce FSH and luteinizing hormone (LH) and release them into the peripheral circulation.</p>
        <p>GnRH release occurs in a pulsatile manner, with low pulse frequencies stimulating more FSH production and high pulse frequencies stimulating more LH production.<xref ref-type="bibr" rid="article-21867.r1">[1]</xref>&#x000a0;Continuous use of GnRH suppresses the release of FSH and LH from the anterior pituitary which inhibits ovulation and estrogen production in women. Clinically, GnRH agonists like leuprolide work via this mechanism.<xref ref-type="bibr" rid="article-21867.r3">[3]</xref></p>
        <p>In women, negative feedback from estrogen levels inhibits FSH secretion.<xref ref-type="bibr" rid="article-21867.r4">[4]</xref>&#x000a0;In men, levels of inhibin B, secreted by the Sertoli&#x000a0;cells in response to FSH, inhibit FSH secretion via negative feedback.<xref ref-type="bibr" rid="article-21867.r5">[5]</xref></p>
      </sec>
      <sec id="article-21867.s4" sec-type="Development">
        <title>Development</title>
        <p>During fetal development, GnRH producing neurons develop from the epithelium of the medial olfactory pit and then migrate to the hypothalamus.<xref ref-type="bibr" rid="article-21867.r6">[6]</xref>&#x000a0;The anterior pituitary gland develops from Rathke&#x02019;s pouch, a portion of the oral cavity.<xref ref-type="bibr" rid="article-21867.r2">[2]</xref>&#x000a0;</p>
        <p>In&#x000a0;the second and third trimesters of pregnancy, as well during the first 3 to 6 months of infancy, the pituitary gland secretes LH and FSH.<xref ref-type="bibr" rid="article-21867.r7">[7]</xref>&#x000a0;LH and FSH levels peak mid-pregnancy as the first ovarian follicle or seminiferous tubule mature.<xref ref-type="bibr" rid="article-21867.r6">[6]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>In males, FSH stimulates Sertoli cell proliferation, which is the most significant contributor to testicular volume in children.<xref ref-type="bibr" rid="article-21867.r7">[7]</xref>&#x000a0;The Sertoli cells produce an anti-mullerian hormone (AMH), which causes the involution of the Mullerian ducts, preventing the formation of female internal genitalia.<xref ref-type="bibr" rid="article-21867.r6">[6]</xref></p>
          </list-item>
        </list>
        <p>Clinical correlation of the early infancy LH and FSH surge:</p>
        <list list-type="bullet">
          <list-item>
            <p>The lack of the normal infancy peak of LH and FSH might identify and diagnose infants, especially males, who have hypogonadotropic hypogonadism. &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Girls with monosomy Turner syndrome (45, XO) have an elevation of FSH up to 6 years old due to lack of negative feedback from nonfunctional ovaries, while girls with mosaicism (45, X/46, XX) have a much lower FSH elevation due to partial ovarian function.<xref ref-type="bibr" rid="article-21867.r6">[6]</xref></p>
          </list-item>
        </list>
        <p>During puberty, the hypothalamus secretes GnRH in a pulsatile manner, which stimulates the anterior pituitary to increase secretion of LH and FSH.<xref ref-type="bibr" rid="article-21867.r6">[6]</xref></p>
      </sec>
      <sec id="article-21867.s5" sec-type="Organ Systems Involved">
        <title>Organ Systems Involved</title>
        <p>
<bold>Hypothalamic-Pituitary-Gonadal Axis</bold>
</p>
        <p>The hypothalamus secretes GnRH, which stimulates the anterior pituitary to release FSH and LH. In females, FSH receptors are located in the granulosa cells of the ovaries. In males, FSH receptors are found in the Sertoli cells of the testes.<xref ref-type="bibr" rid="article-21867.r2">[2]</xref></p>
      </sec>
      <sec id="article-21867.s6" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Females</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Estrogen production</p>
          </list-item>
          <list-item>
            <p>Follicular development</p>
          </list-item>
        </list>
        <p>
<bold>Males</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Induction and maintenance of spermatogenesis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21867.s7" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>
<bold>Females</bold>
</p>
        <p>
<italic toggle="yes">
<bold>Estrogen Production</bold>
</italic>
</p>
        <p>FSH stimulates granulosa cells in the ovarian follicles to synthesize aromatase, which converts androgens produced by the thecal cells to estradiol.</p>
        <p>
<italic toggle="yes">
<bold>Follicular Development and the Menstrual Cycle</bold>
</italic>
</p>
        <p>During the follicular phase of the menstrual cycle, FSH stimulates the maturation of ovarian follicles. As a dominant follicle takes over and secretes estradiol and inhibin, FSH secretion is suppressed. When the dominant follicle produces enough estradiol to maintain levels of 200 to 300 pg/ml for 48 hours, the hypothalamus responds with a surge of GnRH which stimulates the secretion of gonadotropic hormones instead inhibiting them. FSH peaks at the same time as the LH surge that causes ovulation. FSH then remains low throughout the luteal phase, preventing the development of new follicles.<xref ref-type="bibr" rid="article-21867.r2">[2]</xref></p>
        <p>
<bold>Males</bold>
</p>
        <p>FSH, along with testosterone, is necessary for maintaining normal sperm count and function. Studies have shown that FSH deprivation not only lowers sperm count but also affects the quality of the remaining sperm.&#x000a0;<xref ref-type="bibr" rid="article-21867.r8">[8]</xref></p>
      </sec>
      <sec id="article-21867.s8" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Elevated levels of FSH are&#x000a0;associated with unresponsive gonads or hyperfunctioning pituitary adenomas.&#x000a0;Low levels of FSH are associated with either hypothalamic or anterior pituitary dysfunction.</p>
      </sec>
      <sec id="article-21867.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>FSH Levels and&#x000a0;</bold>
<bold>Male Infertility</bold>
</p>
        <p>If males present with small, firm testes and azoospermia or oligospermia, elevated FSH levels can be used to differentiate Klinefelter&#x000a0;syndrome from hypothalamic or pituitary insufficiency. &#x000a0;If testicular size is normal and patients present with azoospermia or oligospermia, FSH levels can be used to determine whether the cause is a primary impairment of spermatogenesis or obstructive. In an obstructive cause of infertility, FSH levels remain normal, while a primary impairment of spermatogenesis will present with elevated FSH levels.</p>
        <p>Several FSH preparations have been used to treat secondary hypogonadism in males. These preparations have been reasonably successful at inducing spermatogenesis and achieving paternity.&#x000a0;<xref ref-type="bibr" rid="article-21867.r8">[8]</xref></p>
        <p>
<bold>Polycystic Ovarian Syndrome</bold>
</p>
        <p>Polycystic ovarian syndrome (PCOS) is a syndrome characterized by elevated androgens, polycystic ovaries, and anovulation.&#x000a0; Patients with PCOS often present with hirsutism, obesity, insulin resistance, menstrual irregularity, and infertility.<xref ref-type="bibr" rid="article-21867.r9">[9]</xref></p>
        <p>In PCOS, the LH:FSH ratio is skewed due to persistently rapid GnRH pulses. These GnRH pulses lead to an increased LH: FSH ratio. This skewed ratio leads to the theca cells of the ovaries producing excess androgen while the granulosa cells do not produce enough aromatase to convert the androgens to estradiol.<xref ref-type="bibr" rid="article-21867.r1">[1]</xref></p>
        <p>
<bold>Hypogonadotropic Hypogonadism</bold>
</p>
        <p>In cases of amenorrhea with low levels of FSH and LH, the fault lies with either the hypothalamus or the pituitary gland.</p>
        <p>
<italic toggle="yes">
<bold>Stress-Induced&#x000a0;</bold>
<bold>Hypogonadotropic Hypogonadism</bold>
</italic>
</p>
        <p>When calorie intake falls short of energy expenditure, the physiological stress decreases hypothalamic GnRH pulse frequency and amplitude, leading to low FSH and LH levels. This explains the anovulation and amenorrhea that can occur in female athletes and individuals with eating disorders due to lack of adequate caloric intake or excessive exercise.<xref ref-type="bibr" rid="article-21867.r2">[2]</xref><xref ref-type="bibr" rid="article-21867.r1">[1]</xref></p>
        <p>
<italic toggle="yes">
<bold>Kallman Syndrome</bold>
</italic>
</p>
        <p>During fetal development, GnRH producing neurons of the hypothalamus develop from the epithelium of the medial olfactory pit and then migrate to their proper place.<xref ref-type="bibr" rid="article-21867.r6">[6]</xref>&#x000a0;In Kallmann&#x000a0;syndrome, a defect in this migratory process leads to the combination of anosmia and hypogonadotropic hypogonadism.<xref ref-type="bibr" rid="article-21867.r2">[2]</xref></p>
        <p>
<bold>Primary Ovarian Insufficiency</bold>
</p>
        <p>In cases of amenorrhea with elevated levels of FSH, the problem lies in the ovaries.</p>
        <p><italic toggle="yes"><bold>Premature ovarian failure</bold></italic> occurs when ovarian failure and menopause occur before age 40. When this happens, FSH levels are&#x000a0;elevated due to the lack of negative feedback from the ovaries.&#x000a0;Although there may be multiple genetic causes, most cases are idiopathic.</p>
        <p><italic toggle="yes"><bold>Turner Syndrome</bold></italic> is the most common genetic disorder causing premature ovarian failure. Turner Syndrome is caused by the loss of an X chromosome (XO karyotype). Girls with Turner&#x000a0;syndrome will present with primary amenorrhea and underdeveloped ovaries (streak ovaries) and elevated FSH levels.<xref ref-type="bibr" rid="article-21867.r10">[10]</xref></p>
        <p>
<bold>Pituitary Adenomas</bold>
</p>
        <p>Pituitary adenomas can develop from any of the cell types in the pituitary.&#x000a0; Pituitary adenomas derived from gonadotropic cells are most often nonfunctioning or function within normal hormone levels and are diagnosed due to symptoms from mass effect rather than hormone secretions. However, in sporadic, these tumors can secrete excess FSH and/or LH and can cause ovarian hyperstimulation.<xref ref-type="bibr" rid="article-21867.r11">[11]</xref>&#x000a0;</p>
        <p>
<bold>Medications</bold>
</p>
        <p>
<italic toggle="yes">
<bold>GnRH Agonists and Antagonists</bold>
</italic>
</p>
        <p>GnRH agonists initially stimulate secretion of LH and FSH, but when given continuously, suppress LH and FSH release. This results in ovarian suppression and decreased estrogen levels. GnRH antagonists can acutely suppress LH and FSH secretion.<xref ref-type="bibr" rid="article-21867.r2">[2]</xref>&#x000a0;&#x000a0;</p>
        <p>Both GnRH agonists and antagonists have a role in the treatment of certain breast and prostate cancers, endometriosis, and uterine leiomyomas.</p>
        <p>
<italic toggle="yes">Assisted Reproduction Techniques (ART)</italic>
</p>
        <p>Techniques such as in vitro fertilization (IVF) and&#x000a0;intracytoplasmic&#x000a0;sperm injection (ICSI) help couples by using FSH to stimulate multiple follicles in the ovaries to harvest multiple eggs for fertilization. FSH is available ias urinary&#x000a0;FSH with or without LH or recombinant&#x000a0;FSH.<xref ref-type="bibr" rid="article-21867.r12">[12]</xref>&#x000a0;GnRH agonists or antagonists can be used during these cycles to prevent the LH surge and ovulation.<xref ref-type="bibr" rid="article-21867.r2">[2]</xref></p>
      </sec>
      <sec id="article-21867.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21867&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21867">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21867/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21867">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21867.s11">
        <title>References</title>
        <ref id="article-21867.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stamatiades</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Kaiser</surname>
                <given-names>UB</given-names>
              </name>
            </person-group>
            <article-title>Gonadotropin regulation by pulsatile GnRH: Signaling and gene expression.</article-title>
            <source>Mol Cell Endocrinol</source>
            <year>2018</year>
            <month>Mar</month>
            <day>05</day>
            <volume>463</volume>
            <fpage>131</fpage>
            <page-range>131-141</page-range>
            <pub-id pub-id-type="pmid">29102564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21867.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbieri</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>The endocrinology of the menstrual cycle.</article-title>
            <source>Methods Mol Biol</source>
            <year>2014</year>
            <volume>1154</volume>
            <fpage>145</fpage>
            <page-range>145-69</page-range>
            <pub-id pub-id-type="pmid">24782009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21867.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yonkers</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Simoni</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Premenstrual disorders.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>218</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-74</page-range>
            <pub-id pub-id-type="pmid">28571724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21867.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shaw</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Histed</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Srouji</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Estrogen negative feedback on gonadotropin secretion: evidence for a direct pituitary effect in women.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>95</volume>
            <issue>4</issue>
            <fpage>1955</fpage>
            <page-range>1955-61</page-range>
            <pub-id pub-id-type="pmid">20133465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21867.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boepple</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Dwyer</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Raivio</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Crowley</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Pitteloud</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Relative roles of inhibin B and sex steroids in the negative feedback regulation of follicle-stimulating hormone in men across the full spectrum of seminiferous epithelium function.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2008</year>
            <month>May</month>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>1809</fpage>
            <page-range>1809-14</page-range>
            <pub-id pub-id-type="pmid">18270253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21867.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lanciotti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cofini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leonardi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Penta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Esposito</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Up-To-Date Review About Minipuberty and Overview on Hypothalamic-Pituitary-Gonadal Axis Activation in Fetal and Neonatal Life.</article-title>
            <source>Front Endocrinol (Lausanne)</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>410</fpage>
            <pub-id pub-id-type="pmid">30093882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21867.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grinspon</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Urrutia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rey</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Male Central Hypogonadism in Paediatrics - the Relevance of Follicle-stimulating Hormone and Sertoli Cell Markers.</article-title>
            <source>Eur Endocrinol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>67</fpage>
            <page-range>67-71</page-range>
            <pub-id pub-id-type="pmid">30349597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21867.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nieschlag</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Simoni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gromoll</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weinbauer</surname>
                <given-names>GF</given-names>
              </name>
            </person-group>
            <article-title>Role of FSH in the regulation of spermatogenesis: clinical aspects.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-46</page-range>
            <pub-id pub-id-type="pmid">10468980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21867.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krishnan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muthusami</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hormonal alterations in PCOS and its influence on bone metabolism.</article-title>
            <source>J Endocrinol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>232</volume>
            <issue>2</issue>
            <fpage>R99</fpage>
            <page-range>R99-R113</page-range>
            <pub-id pub-id-type="pmid">27895088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21867.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pouresmaeili</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fazeli</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Premature ovarian failure: a critical condition in the reproductive potential with various genetic causes.</article-title>
            <source>Int J Fertil Steril</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-12</page-range>
            <pub-id pub-id-type="pmid">24696764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21867.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kihara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sugita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nagai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Saeki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tatsuno</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Seki</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Ovarian hyperstimulation caused by gonadotroph cell adenoma: a case report and review of the literature.</article-title>
            <source>Gynecol Endocrinol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>110</fpage>
            <page-range>110-3</page-range>
            <pub-id pub-id-type="pmid">16603438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21867.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pouwer</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Farquhar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kremer</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Long-acting FSH versus daily FSH for women undergoing assisted reproduction.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Jul</month>
            <day>14</day>
            <volume>2015</volume>
            <issue>7</issue>
            <fpage>CD009577</fpage>
            <pub-id pub-id-type="pmid">26171903</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
